MRSN icon

Mersana Therapeutics

152 hedge funds and large institutions have $590M invested in Mersana Therapeutics in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 37 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

0% more funds holding

Funds holding: 152152 (0)

0% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 20

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
152
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$512K
Puts
$469K
Net Calls
Net Calls Change

Top Sellers

1 -$3.09M
2 -$2.58M
3 -$2.54M
4
Goldman Sachs
Goldman Sachs
New York
-$2.28M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$1.69M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$52.8M
2
$50.8M
3
$44.2M
4
$43.9M
5
$34.3M
6
$26.1M
7
$25.1M
8
$24M
9
$23.4M
10
$21.5M
11
$15.8M
12
$14.8M
13
$13.7M
14
$12.9M
15
$11.8M
16
$10.9M
17
$10.3M
18
$10M
19
$7.2M
20
$6.98M
21
$6.68M
22
$6.63M
23
$6.17M
24
$5.57M
25
$5.3M